Anteris Technologies Global Corp (AVR)

$5.93 -0.27 (-4.35%)
Market Cap 255.43M
Revenue (ttm) 1.91M
Net Income (ttm) -94.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,928.80%
Debt to Equity Ratio -0.16
Volume 1,150,477
Avg Vol 1,176,022
Day's Range N/A - N/A
Shares Out 41.20M
Stochastic %K 22%
Beta 1.15
Analysts Strong Sell
Price Target $15.25

Company Profile

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into dura...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 61 7 3152 3200
Address:
Toowong Tower, Level 3, Suite 302 9 Sherwood Road, Toowong, Australia
Namis
Namis Mar. 9 at 2:01 PM
$AVR new position
0 · Reply
StockNews_Live
StockNews_Live Feb. 26 at 11:01 PM
$AVR Anteris Technologies Global Corp. reported financial results for the full year ended December 31, 2025, and provided a corporate update. Key highlights include the initiation of the global pivotal PAR…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 24 at 9:34 PM
$AVR RSI: 56.31, MACD: 0.1370 Vol: 0.31, MA20: 5.84, MA50: 5.45 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
NeonRSI_404
NeonRSI_404 Feb. 24 at 6:48 PM
$AVR low liquidity name quiet accumulation possible if it keeps holding support
0 · Reply
topstockalerts
topstockalerts Feb. 23 at 6:28 PM
$AVR Curling back up with buyers stepping in 📈. Momentum is building and price is starting to respond. This could be the start of another move.
0 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 5:33 PM
.@SqueezeSharkie operating on another level 🧠❄️ Cold vision, real substance. It doesn’t cost you anything but a click, make sure to follow him🔥 $AVR $INNV $AIRI $SHFS ••
1 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 4:18 PM
$GVH $AVR $DLXY $CBUS •<>
0 · Reply
Polfarer123
Polfarer123 Feb. 20 at 5:58 PM
$AVR new data published but nothing is happening with the stock price ??
0 · Reply
MaryLacy202
MaryLacy202 Feb. 11 at 3:38 PM
$AVR Anteris or unknown; if Anteris Technologies, structural heart medtech; early-stage, high-risk; competes with Edwards, Medtronic.
1 · Reply
twixbarrtwits
twixbarrtwits Feb. 11 at 12:38 PM
$AVR 5.82
0 · Reply
Latest News on AVR
Anteris Technologies Global reports FY results

2026-02-27T12:20:08.000Z - 10 days ago

Anteris Technologies Global reports FY results

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

Jan 22, 2026, 4:02 PM EST - 6 weeks ago

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

Jan 22, 2026, 4:01 PM EST - 6 weeks ago

Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

Anteris Technologies Surges On Pricing Of $200Mln Public Offering

2026-01-21T10:29:11.000Z - 6 weeks ago

Anteris Technologies Surges On Pricing Of $200Mln Public Offering

What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?

2026-01-21T06:38:18.000Z - 6 weeks ago

What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?

Anteris Prices $200 Mln Public Offering; Announces Medtronic Private Placement Up To $90 Mln

2026-01-21T06:13:09.000Z - 6 weeks ago

Anteris Prices $200 Mln Public Offering; Announces Medtronic Private Placement Up To $90 Mln

Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement

2026-01-21T06:10:21.000Z - 6 weeks ago

Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

Jan 20, 2026, 10:53 PM EST - 6 weeks ago

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

Anteris Technologies proposes $200M stock offering, plans Medtronic investment

2026-01-20T21:07:42.000Z - 6 weeks ago

Anteris Technologies proposes $200M stock offering, plans Medtronic investment

Anteris Technologies (AVR) Reports Promising Results for DurAVR THV in Aortic Stenosis

2025-11-17T11:34:16.000Z - 4 months ago

Anteris Technologies (AVR) Reports Promising Results for DurAVR THV in Aortic Stenosis

Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

Nov 17, 2025, 6:00 AM EST - 4 months ago

Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

Sio Capital Management, LLC Reduces Stake in Anteris Technologies Global Corp

2025-11-15T01:52:35.000Z - 4 months ago

Sio Capital Management, LLC Reduces Stake in Anteris Technologies Global Corp

Anteris Announces Results for the Third Quarter of 2025

Nov 12, 2025, 5:52 PM EST - 4 months ago

Anteris Announces Results for the Third Quarter of 2025

Anteris Technologies (AVR) Reports Promising One-Year Results for DurAVR Heart Valve

2025-10-28T23:51:59.000Z - 4 months ago

Anteris Technologies (AVR) Reports Promising One-Year Results for DurAVR Heart Valve

Anteris Technologies (AVR) Advances DurAVR Heart Valve Trial

2025-10-27T23:25:52.000Z - 4 months ago

Anteris Technologies (AVR) Advances DurAVR Heart Valve Trial

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

Oct 27, 2025, 5:43 PM EDT - 4 months ago

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

Anteris Technologies (AVR) to Present Key Clinical Outcomes at TCT 2025

2025-10-27T14:27:10.000Z - 4 months ago

Anteris Technologies (AVR) to Present Key Clinical Outcomes at TCT 2025

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

Oct 27, 2025, 8:43 AM EDT - 4 months ago

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

L1-backed heart medtech Anteris Technologies rakes in $39m

2025-10-26T06:38:13.000Z - 4 months ago

L1-backed heart medtech Anteris Technologies rakes in $39m

Anteris Technologies (AVR) Gains Approval for Global Heart Valve Trial in Denmark

2025-10-15T14:57:36.000Z - 5 months ago

Anteris Technologies (AVR) Gains Approval for Global Heart Valve Trial in Denmark

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

Sep 19, 2025, 2:30 AM EDT - 6 months ago

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

Anteris Technologies (AVR) Reschedules Special Stockholders Meeting

2025-09-11T14:26:24.000Z - 6 months ago

Anteris Technologies (AVR) Reschedules Special Stockholders Meeting

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders

Sep 11, 2025, 8:50 AM EDT - 6 months ago

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders

Anteris Technologies reports Q2 results

2025-08-11T21:45:24.000Z - 7 months ago

Anteris Technologies reports Q2 results

Anteris Announces Results for the Second Quarter of 2025

Aug 11, 2025, 4:52 PM EDT - 7 months ago

Anteris Announces Results for the Second Quarter of 2025

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Jun 9, 2025, 10:52 PM EDT - 9 months ago

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Mon, 31 Mar 2025 07:15:00 -0400 - 1 year ago

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Anteris Reports One-Year Patient Outcomes for DurAVR® THV

Fri, 21 Mar 2025 07:30:00 -0400 - 1 year ago

Anteris Reports One-Year Patient Outcomes for DurAVR® THV

Anteris Technologies Global Corp. reports FY results

2025-03-13T15:07:21.000Z - 1 year ago

Anteris Technologies Global Corp. reports FY results

Anteris Reports 2024 Financial Results and Provides Corporate Update

Wed, 12 Mar 2025 20:33:00 -0400 - 1 year ago

Anteris Reports 2024 Financial Results and Provides Corporate Update

Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast

2025-02-18T14:30:15.000Z - 1 year ago

Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast

Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst

2025-01-07T19:45:28.000Z - 1 year ago

Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

Mon, 16 Dec 2024 19:49:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

U.S. IPO Weekly Recap: ServiceTitan Shines In 3 IPO Week

2024-12-14T03:10:00.000Z - 1 year ago

U.S. IPO Weekly Recap: ServiceTitan Shines In 3 IPO Week

Anteris Technologies prices IPO at $6 per share

2024-12-13T06:10:43.000Z - 1 year ago

Anteris Technologies prices IPO at $6 per share

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

Thu, 12 Dec 2024 22:34:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

Anteris Technologies (AVR) Plans $100 Million IPO on Nasdaq

2024-12-10T08:50:33.000Z - 1 year ago

Anteris Technologies (AVR) Plans $100 Million IPO on Nasdaq

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering

Mon, 09 Dec 2024 07:43:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering

Anteris Technologies Targets $75 Million US IPO

2024-12-03T20:21:26.000Z - 1 year ago

Anteris Technologies Targets $75 Million US IPO

Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering

Sun, 24 Nov 2024 21:08:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering

Cardiac device maker Anteris Technologies files for $75M IPO

2024-11-22T23:54:27.000Z - 1 year ago

Cardiac device maker Anteris Technologies files for $75M IPO

Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study

Mon, 01 Jul 2024 05:30:00 -0400 - 1 year ago

Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study

DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case

Mon, 14 Aug 2023 06:00:00 -0400 - 2 years ago

DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case

Anteris Technologies Commences American Depository Receipt Program

Wed, 09 Aug 2023 06:30:00 -0400 - 2 years ago

Anteris Technologies Commences American Depository Receipt Program

Anteris Technologies Commences US Early Feasibility Study

Wed, 09 Aug 2023 06:00:00 -0400 - 2 years ago

Anteris Technologies Commences US Early Feasibility Study

Namis
Namis Mar. 9 at 2:01 PM
$AVR new position
0 · Reply
StockNews_Live
StockNews_Live Feb. 26 at 11:01 PM
$AVR Anteris Technologies Global Corp. reported financial results for the full year ended December 31, 2025, and provided a corporate update. Key highlights include the initiation of the global pivotal PAR…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 24 at 9:34 PM
$AVR RSI: 56.31, MACD: 0.1370 Vol: 0.31, MA20: 5.84, MA50: 5.45 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
NeonRSI_404
NeonRSI_404 Feb. 24 at 6:48 PM
$AVR low liquidity name quiet accumulation possible if it keeps holding support
0 · Reply
topstockalerts
topstockalerts Feb. 23 at 6:28 PM
$AVR Curling back up with buyers stepping in 📈. Momentum is building and price is starting to respond. This could be the start of another move.
0 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 5:33 PM
.@SqueezeSharkie operating on another level 🧠❄️ Cold vision, real substance. It doesn’t cost you anything but a click, make sure to follow him🔥 $AVR $INNV $AIRI $SHFS ••
1 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 4:18 PM
$GVH $AVR $DLXY $CBUS •<>
0 · Reply
Polfarer123
Polfarer123 Feb. 20 at 5:58 PM
$AVR new data published but nothing is happening with the stock price ??
0 · Reply
MaryLacy202
MaryLacy202 Feb. 11 at 3:38 PM
$AVR Anteris or unknown; if Anteris Technologies, structural heart medtech; early-stage, high-risk; competes with Edwards, Medtronic.
1 · Reply
twixbarrtwits
twixbarrtwits Feb. 11 at 12:38 PM
$AVR 5.82
0 · Reply
AZOZ
AZOZ Feb. 10 at 1:46 PM
$AVR Insider activity!
0 · Reply
AlertsAndNews
AlertsAndNews Feb. 10 at 3:42 AM
$AVR quite the 10%+ buy here L1 Capital Pty Ltd (10%+) purchased 6,333,334 shares at an average price of $5.58 (Form 4).
0 · Reply
FilingTracker
FilingTracker Feb. 10 at 1:53 AM
$AVR Massive $28.75 million purchase by 10% owner: https://www.sec.gov/Archives/edgar/data/1817646/000107997326000185/xslF345X05/ownership.xml
1 · Reply
PowerPlayerPro
PowerPlayerPro Feb. 4 at 4:01 PM
$AVR is a REIT focused on healthcare properties (AvalonBay Communities) or a technology company; without specifics, its performance would depend on its business model.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 3:40 PM
$AVR Really good write-up that perfectly summarizes AVR's present situation. So if you want to bring your AVR knowledge up to date or just discover AVR, this is required reading. https://everyticker.com/quote/AVR/analysis/anteris-technologies-betting-on-biomimetic-innovation-in-the-structural-heart-market-avr
0 · Reply
michaelburryburner
michaelburryburner Feb. 3 at 5:58 PM
$AVR and now the waiting game…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 4:09 AM
$AVR RSI: 76.32, MACD: 0.3826 Vol: 0.79, MA20: 5.48, MA50: 4.99 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OGLars
OGLars Jan. 29 at 3:52 PM
$AVR whats going on here??? Coming back down..?? Where's the entry point
0 · Reply
StockOrTwist
StockOrTwist Jan. 27 at 1:01 PM
$AVR https://www.youtube.com/watch?v=v87kP2BSzeM&list=PLG-rFJE9CyVVwaGfeaM4aC1Sg1pegeEeQ&index=15&pp=gAQBiAQB0gcJCXwKAYcqIYzvsAgC
0 · Reply
rangervs
rangervs Jan. 26 at 7:51 PM
$GLSI keep adding pressure cooker $AMIX near 52 week low worth taking a position $AVR $7+ would be nice
0 · Reply
StockOrTwist
StockOrTwist Jan. 26 at 2:13 PM
$AVR https://www.youtube.com/watch?v=v87kP2BSzeM&list=PLG-rFJE9CyVVwaGfeaM4aC1Sg1pegeEeQ&index=12&pp=iAQB
0 · Reply
michaelburryburner
michaelburryburner Jan. 26 at 2:01 PM
$AVR nice consolidation last week, let’s see what is next
0 · Reply